This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Results

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Treatment with ramipril resulted in the following risk reductions:

  • 25% (p=0.0004) for combined primary outcome
  • 22% for MI
  • 33% for stroke
  • 37% for cardiovascular death
  • 17% revascularisation
  • 24% (p=0.027) for overt nephropathy

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.